United Therapeutics Chairperson, CEO Martine Rothblatt reports sale of 9,500 shares for $5.03 million
UTHR•Option exercise and share sale reported
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported option exercises and share sales on July 20, 2026.
- A family trust acquired 9,500 common shares via option exercise at $135.42.
- The trust sold 9,500 common shares at weighted-average prices ranging from $529.19 to $536.41.
- Trust-held common shares fell to 324,443 following the transactions.
Related News
Butterfly Network director, 10% owner Jonathan M. Rothberg reports $20.76 million share sale
BFLY•
Kidz AI Inc Enters Into Definitive 60-Month Enterprise AI Compute Services Agreement With Canopy Wave With Aggregate Contract Value Of $44.6 Million
KIDZ•
